HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $489,421 | -66.8% | 14,935 | -64.4% | 0.00% | – |
| Q2 2023 | $1,475,658 | +30.4% | 41,934 | +20.9% | 0.00% | – |
| Q1 2023 | $1,132,041 | -17.3% | 34,672 | +39.6% | 0.00% | – |
| Q4 2022 | $1,368,739 | +197.6% | 24,841 | +139.0% | 0.00% | – |
| Q3 2022 | $460,000 | -35.8% | 10,395 | -29.3% | 0.00% | – |
| Q2 2022 | $717,000 | -13.3% | 14,702 | -13.5% | 0.00% | – |
| Q1 2022 | $827,000 | -20.8% | 16,991 | -30.6% | 0.00% | – |
| Q4 2021 | $1,044,000 | -66.8% | 24,469 | -70.2% | 0.00% | -100.0% |
| Q3 2021 | $3,148,000 | +1040.6% | 82,144 | +741.6% | 0.00% | – |
| Q2 2021 | $276,000 | +21.1% | 9,761 | +41.4% | 0.00% | – |
| Q1 2021 | $228,000 | -81.0% | 6,904 | -79.2% | 0.00% | – |
| Q4 2020 | $1,201,000 | +3432.4% | 33,216 | +3221.6% | 0.00% | – |
| Q3 2020 | $34,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |